Skip to main content

Teledyne DALSA announces its new line of high-performance X-ray detectors at RSNA 2022

New Axios IGZO-based X-ray detectors deliver an unrivaled balance of performance and value

Axios X-ray detectors

New Axios X-ray detectors from Teledyne deliver an unprecedented balance of performance and value
New Axios X-ray detectors from Teledyne deliver an unprecedented balance of performance and value

WATERLOO, Ontario, Nov. 22, 2022 (GLOBE NEWSWIRE) — Teledyne DALSA is pleased to announce its presence at the RSNA 2022 Technical Exhibition with a new offering of X-Ray detectors based on Indium Gallium Zinc Oxide (IGZO) in addition to their premium line of CMOS-based detectors. The show takes place November 27 – December 1, Chicago, IL. Teledyne will exhibit its full line of detectors in booth #3709.

Teledyne will introduce its breakthrough line of X-ray detectors that narrows the gap between amorphous silicon and CMOS-based detectors at RSNA 2022. The new Axios flat panel detector series, designed and manufactured entirely by Teledyne, are based on an innovative IGZO technology, proprietary new image chain and use the highest performance components. The Axios product line is engineered to deliver an unprecedented balance of performance and value, while addressing the needs of the most demanding real-time applications for diagnostic and interventional imaging like orthopedics, vascular cardiology and surgery. The high image quality performance of the Axios detectors will enable better diagnosis of medical anomalies and better procedure outcomes, resulting in reduced treatment costs.

“Axios detectors exceed industry benchmarks in current TFT detector technologies by providing artifact-free images at higher speeds and higher DQE at low dose operation with lower lag and an increased signal-to-noise ratio,” said Mila Heeman, Marketing Manager for Teledyne DALSA’s X-Ray Solutions business unit. “The Axios detectors produce high performance 2D and 3D imaging at a considerably lower cost than the premium CMOS technology detectors. We are happy to offer more affordable, high-performance X-ray imaging bearing the Teledyne stamp of excellence in product quality and customer support.”

On display will be also the Teledyne’s Xineos CMOS X-Ray detector series – a superior performance family of detectors that deliver unsurpassed low dose and lag-free image quality, combined with easy integration and long reliable lifetime. These detectors provide the best digital imaging solution for challenging surgical situations — where all other technologies stop working, Teledyne’s CMOS goes the extra mile. Teledyne has a full portfolio of CMOS detectors in a wide range of detector sizes and resolutions for demanding x-ray imaging applications such as surgery, 2D and 3D mammography, extra oral dental, CBCT and others.

About Teledyne DALSA’s Healthcare Products and Services
Teledyne DALSA provides state-of-the-art image sensing, capture and processing solutions to medical, dental and scientific equipment manufacturers. Building on more than 30 years of proven capability and innovation, our team of imaging specialists delivers leading-edge product design. Our manufacturing processes are tailored to comply with the stringent quality, reliability, and traceability requirements of the medical and scientific X-ray community. For more information, visit http://teledynedalsa.com/imaging/markets/medical/

Media Contact:
Geralyn Miller
geralyn.miller@teledyne.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/fe50b5a8-c2fb-4a26-9188-a39f0ca35b74

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.